Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Catasys Inc. (NASDAQ: CATS).

Full DD Report for CATS

You must become a subscriber to view this report.


Recent News from (NASDAQ: CATS)

Catasys Appoints Three Healthcare Executives to Board of Directors
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Edward Zecchini, Sharon Gabrielson, and Diane Seloff to its Board of Directors. Messrs. Rick Anderson and Dave Smit...
Source: Business Wire
Date: November, 01 2018 08:30
Catasys Announces Signing of Agreement with Capital BlueCross
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that it has entered into an agreement with Capital BlueCross, a community-based health insurer serving members in 21 counties in Cent...
Source: Business Wire
Date: October, 31 2018 08:30
Catasys Calls for Improved Engagement to Solve for the Crisis of Untreated Anxiety Disorders in Published Paper Authored by Chief Medical Officer
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that a paper authored by its Senior Vice President and Chief Medical Officer Omar S. Manejwala titled “ Anxiety Disorders: Sco...
Source: Business Wire
Date: September, 27 2018 08:30
Catasys Inc. (CATS) CEO Terren Peizer on Q2 2018 Results - Earnings Call Transcript
Catasys Inc. (CATS) Q2 2018 Earnings Conference Call August 14, 2018 4:30 PM ET Executives Adam Prior - Investor Relations, The Equity Group Terren Peizer - Founder, Chairman of the Board and Chief Executive Officer Richard Anderson - President and Chief Operating Officer Chris...
Source: SeekingAlpha
Date: August, 14 2018 23:47
Catasys beats by $0.04, beats on revenue
Catasys (NASDAQ: CATS ): Q2 EPS of -$0.26 beats by $0.04 . More news on: Catasys Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 16:05
Catasys Reports 2018 Second Quarter Financial Results
Q2 2018 Record Billings of $5.2 Million, Up 152% Year over Year Achieved a Record $2.4 Million in Billings in July 2018, Without Any Special Items Enrolled 1,219 New Members in Q2 2018, Up 289% Year over Year Secured Up to $10 Million in Debt Financing to Support Company...
Source: Business Wire
Date: August, 14 2018 16:01
Catasys to Announce Second Quarter 2018 Results and Host Conference Call on August 14, 2018
Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter and six months ended June 30, 2018, after the closing of...
Source: Business Wire
Date: August, 13 2018 08:00
CORRECTING and REPLACING Catasys to Present at the Canaccord Genuity 38th Annual Growth Conference
Headline of release dated August 1, 2018, should read: Catasys to Present at the Canaccord Genuity 38 th Annual Growth Conference (instead of Catasys to Present at the Cannacord Genuity 38 th Annual Growth Conference). Also, the first paragraph, first sentence should read: Catasys...
Source: Business Wire
Date: August, 01 2018 08:00
Catasys Appoints Industry Veteran Jeremiah Stone to Newly Created Chief Technology Officer Role
Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced Jeremiah Stone’s appointment as the Company’s Chief Technology Officer, a newly created position within the Company. ...
Source: Business Wire
Date: July, 18 2018 08:00
Premarket analyst action - healthcare
Catasys (NASDAQ: CATS ) initiated with Buy rating and $10 (16% upside) price target at Canaccord Genuity. Shares up  1%  premarket. More news on: Catasys Inc., Kiniksa Pharmaceuticals, Scholar Rock Holding, Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: June, 18 2018 08:54

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-089.269.639.799.2634,719
2018-05-185.13135.195.265.1115,201
2018-05-175.13135.195.265.1115,201

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1417,68122,47678.6661Short
2018-12-134,15010,94037.9342Short
2018-12-125,37917,50030.7371Cover
2018-12-119,98626,00338.4033Short
2018-12-103,93710,70436.7806Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CATS.


About Catasys Inc. (NASDAQ: CATS)

Logo for Catasys Inc. (NASDAQ: CATS)

Catasys, Inc. provides data analytics based specialized behavioral health management and integrated treatment services to health plans through our OnTrak solution. Our OnTrak solution is designed to improve member health and at the same time lower costs to the insurer for underserved populations where behavioral health conditions are causing or exacerbating co existing medical conditions. The program utilizes proprietary analytics, member engagement and patient centric treatment that integrates evidence based medical and psychosocial interventions along with care coaching in a week outpatient program. Our initial focus was members with substance use disorders, but we have expanded our solution to assist members with anxiety and depression. We currently operate our OnTrak solutions in Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. We provide services to commercial employer funded , managed Medicare Advantage, and managed Medicaid and duel eligible Medicare and Medicaid populations.

 

Contact Information

 

 

Current Management

  • Terren S. Peizer / CEO
  • Richard A. Anderson / President, COO, IR Manager
  • Susan Etzel / CFO
  • Mintz Levin / Securities Counsel
  • Terren S. Peizer / Chairman
  • Richard Berman /
  • Marc Cummins /
  • Steve Gorlin /
  • Marvin Igelman / Director
    • Marvin Igelman ventured into the technology field in and successfully founded Brandera Inc., a publicly traded company, where he served as its President and CEO operating Portfolios.com, a leading online businesstobusiness site for the Graphic Arts and creative community. Following the sale of Portfolios.com, Mr. Igelman served as a business development consultant for numerous technology companies, and established a number of other successful ventures including funding and serving as CEO of Unomobi Inc., a mobile advertising and messaging platform that was acquired in by Poynt Corporation. Mr. Igelman joined the Poynt Corporation executive team and board of directors, serving as its Chief Strategy Officer until June . Mr. Igelman also serves on the board of directors of Catasys Inc. Mr. Igelman graduated from Osgoode Hall Law School in , becoming a member of the Law Society of Upper Canada in .
  • Dave Smith /

Current Share Structure

  • Market Cap: $73,200,587 - 03/15/2018
  • Issue and Outstanding: 15,913,171 - 03/02/2018

 


Recent Filings from (NASDAQ: CATS)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 07 2018

 

 


Daily Technical Chart for (NASDAQ: CATS)

Daily Technical Chart for (NASDAQ: CATS)


Stay tuned for daily updates and more on (NASDAQ: CATS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CATS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CATS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CATS and does not buy, sell, or trade any shares of CATS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/